ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Revvity Inc

Revvity Inc (RVTY)

112,95
-0,81
(-0,71%)
Geschlossen 07 Juli 10:00PM
113,51
0,56
( 0,50% )
Vor Marktöffnung: 11:43AM

Revvity Inc (RVTY) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
113,51
( 0,50% )
Gebot
-
Fragen
-
Volumen
706
0,00 Tagesbereich 0,00
81,22 52-Wochen-Bereich 118,2999
Marktkapitalisierung
Handelsende
112,95
Handelsbeginn
-
Letzter Handelszeitpunkt
11:43:24
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
US$ 1.431.708
Ausgegebene Aktien
111.559.773
Dividendenrendite (LTM)
0,28 (0,29%)
Kurs-Gewinn-Verhältnis
54,46
Gewinn pro Aktie (EPS)
2,1
Erlöse (LTM)
2,9B
Nettogewinn (LTM)
239,68M

Über Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early ... Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
Waltham, United States
Gegründet
2026
Revvity Inc is listed in the Healthcare sector of the New York Börse with ticker RVTY. The last closing price for Revvity was US$112,95. Over the last year, Revvity shares have traded in a share price range of US$ 81,22 to US$ 118,2999.

Revvity currently has 111.559.773 shares in issue. The market capitalisation of Revvity is US$12,66 billion. Revvity has a price to earnings ratio (PE ratio) of 54.46.

RVTY Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-2.12-1.83343422987115.63115.63109.621481927112.33983862CS
412.0311.8545526212101.48116.1696.8551563579106.77581918CS
1221.0122.713513513592.5116.1681.22149089199.24011626CS
268.37.88898393689105.21118.299981.22137778499.47320663CS
5212.6312.5198255353100.88118.299981.22136651796.69783952CS
156-2.02-1.74846360253115.5313279.51054836102.83807212CS
260-2.83-2.43252535671116.3413279.51044208103.30816326CS

RVTY - Frequently Asked Questions (FAQ)

What is the current Revvity Inc share price?
The current share price of Revvity Inc is US$ 113,51
How many Revvity Inc shares are in issue?
Revvity Inc has 111.559.773 shares in issue
What is the market cap of Revvity Inc?
The market capitalisation of Revvity Inc is USD 12,66B
What is the 1 year trading range for Revvity Inc share price?
Revvity Inc has traded in the range of US$ 81,22 to US$ 118,2999 during the past year
What is the PE ratio of Revvity Inc?
The price to earnings ratio of Revvity Inc is 54,46
What is the cash to sales ratio of Revvity Inc?
The cash to sales ratio of Revvity Inc is 4,37
What is the registered address of Revvity Inc?
The registered address for Revvity Inc is 77 4th Avenue, Waltham, Massachusetts, 02451
What is the Revvity Inc website address?
The website address for Revvity Inc is www.revvity.com
Which industry sector does Revvity Inc operate in?
Revvity Inc operates in the Biotechnology & Life Sciences sector

RVTY Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen